Dentox: Botox Training & Certification
Dentox is an industry leader in continuing education providers with the experience and expertise necessary to provide you with the skills you need. When you tell your patients and staff you were trained by Dentox, you’re telling them you were trained by one of the best. In fact, Dentox lead instructor and course director Dr. Howard Katz, DDS, is a recognized innovator in Botox certification, who is named on the Botulinum toxin patent applications.
Dr. Katz is also a medical innovator and practicing general dentist. In addition to his work with Botox, Dysport and Xeoman, his name is also on the patent application for gel dermal filler formulations and Oraverse, an anesthetic reversal product. He also led research into using sugar alcohols like xylitol and sorbitol in dentistry almost 40 years ago and is responsible for introducing Botox along with gel filler injections into dental offices over a decade ago. As the leader of the Dentox live patient training program, Dr. Katz continues to innovate, updating and improving courses all the time so that they maintain their cutting-edge status.
Dentox offers revolutionary and forward-looking gel filler and Botox certificaiton courses given by a proven scientific mind - who is also a respected dentist, clinician and professional named on the intellectual property registrations for a variety of cosmetic products.
This medical and dental course training organization is based in California and respects the Dental Practice Act of every state in which it offers training. We further differentiate our company from others by avoiding recommending treatments that have proven ineffective or materials that can damage your reputation or ours.
Dentox is a PACE Provider approved by the Academy of General Dentistry (309473). This training company’s formal continuing education courses are accepted by the AGD for credit toward Fellowship, Mastership and membership maintenance. This approval does not imply any acceptance by a state or other board of dentistry or endorsement by AGD. The current approval term is from February 1, 2014 until January 31, 2016.